Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sharmila Patel & Mark R Player. (2008) Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer. Expert Opinion on Investigational Drugs 17:12, pages 1865-1882.
Read now
Read now
Rachel Suter & James A Marcum. (2007) The molecular genetics of breast cancer and targeted therapy. Biologics: Targets and Therapy 1:3, pages 241-258.
Read now
Read now
Marek Gniazdowski, William A Denny, Stephanie M Nelson & Malgorzata Czyz. (2005) Effects of anticancer drugs on transcription factor–DNA interactions. Expert Opinion on Therapeutic Targets 9:3, pages 471-489.
Read now
Read now
Articles from other publishers (13)
Madhavi Gangapuram, Elizabeth A. Mazzio, Kinfe K. Redda & Karam F. A. Soliman. (2021) Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to Paclitaxel. International Journal of Molecular Sciences 22:14, pages 7694.
Crossref
Crossref
Yong Li, Dong Liu, Zhongbin Cheng, Peter Proksch & Wenhan Lin. (2017) Cytotoxic trichothecene-type sesquiterpenes from the sponge-derived fungus Stachybotrys chartarum with tyrosine kinase inhibition. RSC Advances 7:12, pages 7259-7267.
Crossref
Crossref
Kuo-Feng Tai & Chien-Hsing Wang. (2013) Using Adenovirus Armed Short Hairpin RNA Targeting Transforming Growth Factor β1 Inhibits Melanoma Growth and Metastasis in an Ex Vivo Animal Model. Annals of Plastic Surgery 71:Supplement 1, pages S75-S81.
Crossref
Crossref
Sergey A. Kaliberov & Donald J. Buchsbaum. 2012. Applications of viruses for cancer therapy. Applications of viruses for cancer therapy
221
263
.
Hyun Ah Kim, Taiyoun Rhim & Minhyung Lee. (2011) Regulatory systems for hypoxia-inducible gene expression in ischemic heart disease gene therapy. Advanced Drug Delivery Reviews 63:8, pages 678-687.
Crossref
Crossref
Junchuan Li, Hongyu Zhu, Tingxuan Chen, Guihua Dai & Lanying Zou. (2011) TGF-?1 and BRCA2 Expression are Associated with Clinical Factors in Breast Cancer. Cell Biochemistry and Biophysics 60:3, pages 245-248.
Crossref
Crossref
Svitlana I. Shpyleva, Volodymyr P. Tryndyak, Olga Kovalchuk, Athena Starlard-Davenport, Vasyl’ F. Chekhun, Frederick A. Beland & Igor P. Pogribny. (2010) Role of ferritin alterations in human breast cancer cells. Breast Cancer Research and Treatment 126:1, pages 63-71.
Crossref
Crossref
Nancy Smyth TempletonKarsten Brand. 2008. Gene and Cell Therapy. Gene and Cell Therapy.
Dragomira Majhen & Andreja Ambriović-Ristov. (2006) Adenoviral vectors—How to use them in cancer gene therapy?. Virus Research 119:2, pages 121-133.
Crossref
Crossref
T. Robson, J. Worthington, S. R. McKeown & D. G. Hirst. (2016) Radiogenic Therapy: Novel Approaches for Enhancing Tumor Radiosensitivity. Technology in Cancer Research & Treatment 4:4, pages 343-361.
Crossref
Crossref
S E Theocharis, A P Margeli, J T Klijanienko & G P Kouraklis. (2004) Metallothionein expression in human neoplasia. Histopathology 45:2, pages 103-118.
Crossref
Crossref
Cynthia Osborne, Paschal Wilson & Debu Tripathy. (2004) Oncogenes and Tumor Suppressor Genes in Breast Cancer: Potential Diagnostic and Therapeutic Applications. The Oncologist 9:4, pages 361-377.
Crossref
Crossref
Jing Zhao, Li-Hong Zhang, Lin-Tao Jia, Li Zhang, Yan-Ming Xu, Zhi Wang, Cui-Juan Yu, Wei-Dan Peng, Wei-Hong Wen, Cheng-Ji Wang, Si-Yi Chen & An-Gang Yang. (2004) Secreted Antibody/Granzyme B Fusion Protein Stimulates Selective Killing of HER2-overexpressing Tumor Cells. Journal of Biological Chemistry 279:20, pages 21343-21348.
Crossref
Crossref